当引流管触及脑组织:慢性硬膜下血肿钻孔引流术后引流管误置的发生率与相关并发症
本文回顾性分析2家机构连续接受钻孔引流治疗慢性硬膜下血肿的463例患者,其中290例(62.6%)置入硬膜下引流管(SDD),引流管误置发生于73例(15.8%),其中5例(6.9%)出现医源性出血、9例(12.3%)出现神经系统症状。多因素分析显示维生素K拮抗剂(OR 3.64)、其他口服抗凝药(OR 10.24)及术前格拉斯哥昏迷评分低(OR 7.81)与误置相关,误置与术后出血(OR 5.81)、更长手术时间(OR 1.01)和住院时间(OR 1.08)相关。
要点
- 463例中290例(62.6%)置入硬膜下引流管,引流管误置73例(15.8%)。
- 误置患者中5例(6.9%)出现医源性出血,9例(12.3%)出现神经系统症状。
- 维生素K拮抗剂(OR 3.64)、其他口服抗凝药(OR 10.24)及术前格拉斯哥昏迷评分低(OR 7.81)为误置的相关危险因素。
核心结论
- 硬膜下引流管误置的发生不可忽视,因其导致医源性引流管相关并发症,并似乎影响钻孔引流治疗慢性硬膜下血肿患者的出血事件和住院时间。
研究设计与样本
- 回顾性分析2家机构连续接受钻孔引流治疗慢性硬膜下血肿的患者队列,共纳入463例,分析引流管类型(骨膜下引流管 vs. 硬膜下引流管)、引流管误置率及引流管相关并发症。
- 在硬膜下引流管亚组中,采用单因素和多因素分析探讨引流管误置及并发症的潜在危险因素。
主要发现
- 463例中290例(62.6%)接受硬膜下引流管;引流管误置发生于73例(15.8%)。
- 误置患者中5例(6.9%)发生医源性出血,9例(12.3%)出现神经系统症状。
- 多因素分析后,维生素K拮抗剂(OR 3.64)、其他口服抗凝药(OR 10.24)及术前格拉斯哥昏迷评分低(OR 7.81)仍为引流管误置的相关危险因素。
- 多因素分析后,引流管误置患者与术后出血(OR 5.81)、更长手术时间(OR 1.01)和更长住院时间(OR 1.08)呈强关联。
关键数值与推荐
- 引流管误置定义为引流管位置不正确并超出硬膜下腔,分为无影像学后遗症的误置、导致影像学确认的医源性出血的误置和导致神经系统症状的误置。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The insertion of a subdural drain (SDD) after burr-hole drainage of chronic subdural hematoma (cSDH) was shown to reduce recurrence rate and improve outcome at 6 months. However, studies analyzing the rate of drain misplacement and complications associated with drain misplacement are sparse. METHODS: We analyzed retrospectively a cohort of consecutive patients undergoing burr-hole drainage for cSDH in 2 institutes. Drain type (subperiosteal drain vs. SDD), drain misplacement rate, and drain-associated complications were analyzed. We explored potential risk factors for drain misplacement and associated complications in the SDD subgroup using univariate and multivariate analysis. Drain misplacement was defined as incorrect drain position exceeding the subdural cavity and was categorized into drain misplacement without radiologic sequelae, drain misplacement causing radiologically confirmed iatrogenic bleeding, and drain misplacement causing neurologic symptoms. RESULTS: Of 463 included patients, 290 (62.6%) received an SDD. Drain misplacement occurred in 73 patients (15.8%). In 5 (6.9%) and 9 (12.3%) of these patients, iatrogenic bleeding and neurologic symptoms occurred, respectively. Intake of vitamin K antagonists (odds ratio [OR], 3.64) or different oral anticoagulants (OR, 10.24), and low preoperative Glasgow Coma Scale score (OR, 7.81) remained associated risk factors for drain misplacement after multivariate analysis. Patients with misplaced drains showed a strong association with postoperative bleeding (OR, 5.81), longer operation time (OR, 1.01), and hospitalization time (OR, 1.08) after multivariate analysis. CONCLUSIONS: The occurrence of SDD misplacement is unignorable, because it leads to iatrogenic drain-associated complications and seems to affect bleeding events and hospitalization time of patients undergoing burr-hole drainage of cSDH.
引用
- Kamenova M, Wanderer S, Lipps P, et al. When the Drain Hits the Brain. World Neurosurg. 2020. PMID: 32147547. doi:10.1016/j.wneu.2020.02.166
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。